Zimmer Biomet Holdings, Inc.

    Jurisdiction
    United States
    LEI
    2P2YLDVPES3BXQ1FRB91
    ISIN
    US98956P1021 (ZBH)
    Sectors
    1. Healthcare
    2. Medical - Devices

    Scores

    InsiderPie Expert Score
    51 / 100
    Even with peer group:
    51 / 100
    Fair value (Benjamin Graham formula)
    €142.10 68.5% undervalued
    Financial strength (Piotroski F-Value)
    5 / 9
    Fundamental strength relative to industry (Mohanram G-Value)
    5 / 7

    Profile

    Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. Read full profile

    Fundamentals

    Net revenue
    €6.68B
    Gross margin
    68.8%
    EBIT
    €1.08B
    EBIT margin
    16.1%
    Net income
    €702.32M
    Net margin
    10.5%

    Statement period: - (published )

    Estimates

    Fiscal Year Net revenue Net income
    €7.43B +11.2% €1.46B +107.3%
    €7.79B +4.9% €1.59B +9.0%
    €8.26B +6.0% €1.71B +7.9%

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Dividends

    Last dividend amount
    $0.24
    Ex date
    Payment date
    Dividend payout ratio
    23.4%

    Analyst ratings

    No analyst ratings available

    Insider Transactions

    Name Title Transaction Date Shares Price Value
    Winkler Lori SVP and CHRO -1.5K $102.49 -$153.74K

    Congress transactions

    Name Transaction date Value
    Robert Bresnahan May 31, 2025 $1.00K–$15.00K
    Robert Bresnahan May 8, 2025 $1.00K–$15.00K
    Julie Johnson March 12, 2025 $1.00K–$15.00K

    Investor transactions

    Name Shares Value Last change Change type
    Ray Dalio 8.5K $964.41K -192K Sell

    Earnings Calls

    Add to watchlist

    Notifications